In this study, we hypothesized that a systematic analysis of gene expression alterations in brain samples obtained from postmortem AD and PSP patients, as well as amyloid and tau pathology animal models, could contribute to disentangle cellular processes affected at different stages of disease progression. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.